Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wittmer

Showing results (361-370 of 600) with videos related to

Pageof 60
Sort By:
Plos One|June 2, 2015
Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate CancersChristoph Burdelski, Erzen Bujupi, Maria Christina Tsourlakis, et al.
Brain : a Journal of Neurology|June 12, 2021
NPT520-34 improves neuropathology and motor deficits in a transgenic mouse model of Parkinson's diseaseAsma Khan, Robert Johnson, Carrie Wittmer, et al.
Oncology Letters|October 19, 2018
High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastasesFranziska Brandi, Katharina Grupp, Claudia Hube-Magg, et al.
The Science of the Total Environment|December 7, 2016
The science, policy and practice of nature-based solutions: An interdisciplinary perspectiveCarsten Nesshöver, Timo Assmuth, Katherine N Irvine, et al.
The Prostate|January 15, 2016
Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancerNathaniel Melling, Berivan Taskin, Claudia Hube-Magg, et al.
Plos One|August 1, 2015
High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate CancerNathaniel Melling, Levon Harutyunyan, Claudia Hube-Magg, et al.
Oncology Reports|July 3, 2015
Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletionKatharina Grupp, Laura Roettger, Martina Kluth, et al.
Plos One|May 11, 2010
Determination of angptl4 mRNA as a diagnostic marker of primary and metastatic clear cell renal-cell carcinomaJérôme Verine, Jacqueline Lehmann-Che, Hany Soliman, et al.
Plos One|October 30, 2013
Improved glucose control and reduced body weight in rodents with dual mechanism of action peptide hybridsJames L Trevaskis, Christine M Mack, Chengzao Sun, et al.
Human Pathology|November 29, 2015
Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrenceAlexandra Pust, Dominik Kylies, Claudia Hube-Magg, et al.
Pageof 60

Showing results (361-370 of 600) with videos related to

Sort By:
Pageof 60
Plos One|June 2, 2015
Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate CancersChristoph Burdelski, Erzen Bujupi, Maria Christina Tsourlakis, et al.
Brain : a Journal of Neurology|June 12, 2021
NPT520-34 improves neuropathology and motor deficits in a transgenic mouse model of Parkinson's diseaseAsma Khan, Robert Johnson, Carrie Wittmer, et al.
Oncology Letters|October 19, 2018
High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastasesFranziska Brandi, Katharina Grupp, Claudia Hube-Magg, et al.
The Science of the Total Environment|December 7, 2016
The science, policy and practice of nature-based solutions: An interdisciplinary perspectiveCarsten Nesshöver, Timo Assmuth, Katherine N Irvine, et al.
The Prostate|January 15, 2016
Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancerNathaniel Melling, Berivan Taskin, Claudia Hube-Magg, et al.
Plos One|August 1, 2015
High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate CancerNathaniel Melling, Levon Harutyunyan, Claudia Hube-Magg, et al.
Oncology Reports|July 3, 2015
Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletionKatharina Grupp, Laura Roettger, Martina Kluth, et al.
Plos One|May 11, 2010
Determination of angptl4 mRNA as a diagnostic marker of primary and metastatic clear cell renal-cell carcinomaJérôme Verine, Jacqueline Lehmann-Che, Hany Soliman, et al.
Plos One|October 30, 2013
Improved glucose control and reduced body weight in rodents with dual mechanism of action peptide hybridsJames L Trevaskis, Christine M Mack, Chengzao Sun, et al.
Human Pathology|November 29, 2015
Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrenceAlexandra Pust, Dominik Kylies, Claudia Hube-Magg, et al.
Pageof 60